Detalhe da pesquisa
1.
Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations.
Psychooncology
; 28(8): 1679-1686, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31152683
2.
Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women.
Breast Cancer Res Treat
; 166(2): 631-639, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28779219
3.
Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation.
Cancers (Basel)
; 14(13)2022 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35805038
4.
No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in BRCA1 or BRCA2 Mutation Families.
Genes (Basel)
; 12(7)2021 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34356116
5.
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing.
Eur J Cancer
; 146: 30-47, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33578357
6.
Role of the general practitioner in the care of BRCA1 and BRCA2 mutation carriers: General practitioner and patient perspectives.
Mol Genet Genomic Med
; 6(6): 957-965, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30308700
7.
Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations.
Eur J Hum Genet
; 26(12): 1732-1742, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30089825